title: A case of monosymptomatic hypochondriacal psychosis treated with olanzapine.
abstract: OBJECTIVE
  To emphasize the availability of safer alternatives to currently standard therapy for monosymptomatic hypochondriacal psychosis (MHP).
  
  
  METHODS
  We report a case of treatment of monosymptomatic hypochondriacal psychosis in an elderly woman with the atypical neuroleptic olanzapine.
  
  
  RESULTS
  Treatment with rather low doses of olanzapine led to complete resolution of delusional symptoms.
  
  
  CONCLUSIONS
  Olanzapine, like other atypical neuroleptic agents, shows promise as a treatment for this syndrome, and it offers considerable safety and side-effect advantages over older agents.
authors.affiliation: University of Maryland Medical System, Baltimore, Maryland 21201, USA. EWeintra@UMPSY.UMaryland.edu
authors.forename: E
authors.initials: E
authors.lastname: Weintraub
authors.forename: C
authors.initials: C
authors.lastname: Robinson
mesh_terms: D000368:Aged; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001569:Benzodiazepines; D005260:Female; D006801:Humans; D006998:Hypochondriasis / Q000188:drug therapy* / Q000523:psychology; D000077152:Olanzapine; D010890:Pirenzepine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D011618:Psychotic Disorders / Q000188:drug therapy* / Q000523:psychology; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D010890:Pirenzepine; D000077152:Olanzapine